Clinical Trial Update: Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating maintenance therapy with Uracil-tegafur (UFT) or Bacillus Calmette-Guérin (BCG) to prevent recurrences in non-muscle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) (Bacillus Calmette-Guérin)
• Uracil-tegafur (UFT) (uracil-tegafur)

Snippet

Sponsor: Urological Oncology Council of Northern Tokyo | Conditions: Bladder Cancer | Phase 3 | Status: UNKNOWN